Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty

Go back to Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty

Pfizer (PFE) Settles Detrol LA Litigation with Mylan (MYL)

September 7, 2012 8:03 AM EDT

Pfizer, Inc. (NYSE: PFE) has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. (Nasdaq: MYL) relating to Pfizers patents covering Detrol LA (tolterodine tartrate) extended-release capsules.

As a result of this settlement, and past... More

Mylan (MYL) Launches GBR App for Apple iPad, iPod, and iPhone Devices

September 6, 2012 7:43 AM EDT

Mylan Inc. (Nasdaq: MYL) has launched the first ever app of its Generic Brand Reference (GBR) Guide, a free reference and educational tool that helps U.S. health care professionals, patients and pharmacy students to quickly identify the generic name for a brand... More